Insider · CIK 0001275857
James A McNulty
Files at INTI (Inhibitor Therapeutics, Inc.), LNAI (RENOVARO INC.). First filing -, latest -.
In brief
James A McNulty files SEC Form 4 as director and CFO at INTI (Inhibitor Therapeutics, Inc.), and also at LNAI (RENOVARO INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James A McNulty has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | INTI Inhibitor Therapeutics, Inc. | GGift Common Stock | -3,200,000 | $0.00 | $0 | 19,901,057 | Aug 4, 2026 |
| Nov 4, 2024 | LNAI RENOVARO INC. | AGrant or award Option to purchase shares of common stockderivative | +120,968 | $0.00 | $0 | 120,968 | Nov 6, 2024 |
Questions about James A McNulty
Answered from the filings on this page, as of the latest one.
Is James A McNulty buying or selling?
James A McNulty has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James A McNulty's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James A McNulty has 0.
Where does James A McNulty file Form 4?
James A McNulty has filed Form 4 at INTI (Inhibitor Therapeutics, Inc.) as Chief Financial Officer; LNAI (RENOVARO INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.